glp 1 agonists muscle loss Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity? The Influence of Glucagon-like Peptide-1
Description
The large image can be enlarged further using the zoom button by the main image
Direct weight loss coverage for Zepbound is excluded under most Anthem plans
Over half (56%) of GLP-1 users say they started making healthier food choices during treatment
The relative proportion of incident patients dispensed these drugs outside the benefit increased by 59% between 2019 and 2023 (see Table 7 in the Appendix)
Surgery, Anesthesia and GLP-1 Weight Loss Medicines: The Unseen Danger David S
FDA (2021)
